The All Wales Medicines Strategy Group started the assessment of ivacaftor (Kalydeco) as soon as the drug company formally engaged with the appraisal process. This process is recognised to be robust and normally takes about 21 weeks to allow all parties, including patient organisations such as the Cystic Fibrosis Trust, to submit their comments. The final appraisal decision for Kalydeco is scheduled to be reached at a public meeting on 8th May 2013.
More top news
A family has issued an appeal to help find their missing pet turkey - in case he gets gobbled up as someone's Christmas dinner.
A blustery start to the weekend with sunny spells and scattered showers.
Welsh Secretary Stephen Crabb has launched an attack on Labour leader Ed Miliband, saying he "doesn't give a toss about Wales".